Prijeđi na sadržaj

Aceklidin

Izvor: Wikipedija
Aceklidin
(IUPAC) ime
1-azabiciklo[2.2.2]oct-3-il acetat
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 827-61-2
6109-70-2 (HCl)
ATC kod S01EB08
PubChem[1][2] 1979
ChemSpider[3] 1902
UNII 0578K3ELIODaY
KEGG[4] D02750DaY
ChEMBL[5] CHEMBL20835DaY
Hemijski podaci
Formula C9H15NO2
Mol. masa 169,221 g/mol
SMILES eMolekuli&PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Prescription only
Način primene Ocularno

Aceklidin(Glaukostat,Glaunorm,Glaudin) jeparasimpatomimetičkimiotičkiagens koji se koristi za tretiranjeglaukomauskog ugla. On umanjuje intraokularni pritisak.

Nepoželjna dejstva

[uredi|uredi kod]

Nepoželjna dejstva aceklidina su povećana salivacija ibradikardija(pri primeni prekomernih doza).

Mehanizam dejstva

[uredi|uredi kod]

Aceklidin deluje kaoagonistmuskarinskog acetilholinskog receptora.[6]

Reference

[uredi|uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.”.Drug Discov Today15(23-24): 1052-7.DOI:10.1016/j.drudis.2010.10.003.PMID20970519.edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4:217-241.DOI:10.1016/S1574-1400(08)00012-1.
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010).„Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”.J Cheminform2(1): 3.DOI:10.1186/1758-2946-2-3.PMID20331846.edit
  4. Joanne Wixon, Douglas Kell (2000).„Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”.Yeast17(1): 48–55.DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
  6. Shannon HE, Hart JC, Bymaster FP,et al.(August 1999).„Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats”.J. Pharmacol. Exp. Ther.290(2): 901–7.PMID10411607.

Povezano

[uredi|uredi kod]